Lv2
200 积分 2025-08-11 加入
UPLC-MS assessment on the structural similarity of recombinant human erythropoietin (rhEPO) analogues from manufacturers in China for attribute monitoring
6天前
已完结
Evaluation of erythropoietin biosimilars Epotin™, Hemax® and Jimaixin™ by electrophoretic methods used for doping control analysis and specific N-glycan analysis revealed structural differences from original epoetin alfa drug Eprex®
13天前
已完结
Benchmark Glycan Profile of Therapeutic Monoclonal Antibodies Produced by Mammalian Cell Expression Systems
16天前
已完结
Glycan Profiles of FDA-Approved Therapeutic Antibodies: Insights from Regulatory Submissions
16天前
已完结
Targeting the TGFβ signalling pathway in disease
1个月前
已完结
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
1个月前
已完结
Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab
2个月前
已完结
A place for biosimilars in the changing multiple sclerosis treatment landscape
2个月前
已完结
Evaluation of Ocrelizumab (Xacrel) on Walking Ability in Multiple Sclerosis Patients: A First Report from Iran
2个月前
已完结
Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial
2个月前
已关闭
皖公网安备34019202002308
